Compare Salesforce Inc (CRM) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs Medtronic PLC — how do they compare? Salesforce Inc trades at $193 (market cap $161.73B), while Medtronic PLC trades at $90.02 (market cap $116.07B). The key difference: Salesforce Inc is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| CRM | MDT | |
|---|---|---|
Market Cap | $161.73B | $116.07B |
Sector | Technology | Health |
52-Week High | $266.23 | $105.35 |
52-Week Low | $150.12 | $73.75 |
Enterprise Value | $191.77B | $134.82B |
Dividend Yield | 0.89% | 3.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $192.28, down 2.65% today amid a broader tech sell-off, but maintains strong fundamentals with consistent earnings beats, robust profitability margins, and solid cash flow growth. The stock exhibits a bullish technical trend with key support at $193, while analyst consensus remains overwhelmingly positive with a $230.83 price target. Recent news highlights AI-driven growth potential but also sector-wide volatility concerns.
Outlook is favorable given CRM's rule of 44 performance, AI monetization momentum, and discounted valuation, though risks include competitive pressures, macroeconomic headwinds, and elevated RSI levels suggesting near-term overbought conditions. The company's double-digit revenue growth and expanding margins support long-term upside if execution continues.
Medtronic (MDT) trades at $89.99, up 0.65% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with consistent earnings beats, 13.2% net income margin, and positive cash flow trends. Recent product innovations including the Hugo robotic surgery platform and AI surgical tools position MDT for growth. Analyst consensus remains strongly positive with 60% buy ratings and $98.75 price target.
MDT presents a compelling investment case with steady revenue growth, dividend aristocrat status, and technological leadership in medical devices. Key risks include increasing debt levels and competitive pressures from Intuitive Surgical. The stock's current valuation at 24.31 P/E appears reasonable given growth prospects, with upside potential to consensus targets if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
